ARTICLE | Clinical News
Phase II data for ISIP in psoriasis
June 25, 2001 7:00 AM UTC
ISIP reported that its ISIS 2302, a topical antisense inhibitor of Intercellular Adhesion Molecule -1 ( ICAM-1), showed a trend toward a relationship between compound concentration and reduction of pl...